Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genesen invests in medtech for Buenos Aires operations:

This article was originally published in Clinica

Executive Summary

Argentine private healthcare group Genesen is committing a further US$255,000 investment in medical equipment at the Clinica Santa Maria, in Villa Ballester, Buenos Aires. The ongoing investment aims to consolidate its regional market leadership. Over the last two years, the centre has been equipped to perform cardiovascular surgery, computed tomography and haemodynamics. It was also recently appointed to perform bariatric (gastric by-pass) surgery, under what the company described as an "exclusive arrangement". Among the services offered at its private clinics are A&E; diagnostics; maternity; neonatal intensive care; and intensive care attached to its cardiovascular surgery units. In addition, Genesen operates a network of diagnostic centres in the federal district and greater Buenos Aires.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel